Scarica l'app Stockscreener
3.62
4.74%
-0.18
Dopo l'orario di chiusura:
3.65
0.03
+0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$3.80
Aprire:
$3.77
Volume 24 ore:
4.04M
Relative Volume:
0.96
Capitalizzazione di mercato:
$934.64M
Reddito:
$427.68M
Utile/perdita netta:
$-58.06M
Rapporto P/E:
-15.20
EPS:
-0.2382
Flusso di cassa netto:
$-37.50M
1 W Prestazione:
-2.43%
1M Prestazione:
-9.50%
6M Prestazione:
-40.85%
1 anno Prestazione:
-45.48%
Intervallo 1D:
$3.61
$3.78
Intervallo di 1 settimana:
$3.61
$3.915
Portata 52W:
$3.61
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.62 | 981.11M | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx at cantor global healthcare conference: growth meets payer pressure - Investing.com
ARDX: Profitability targeted by 2027 as IBSRELA and XPHOZAH drive growth amid payer and market shifts - TradingView
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx Inc (ARDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ardelyx (ARDX) Has Investors Looking Closer, But What Is Driving The Attention? - simplywall.st
Ardelyx CHRO James Brady sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx CHRO James Brady sells $58,378 in stock - Investing.com
Ardelyx to Participate in Upcoming Investor Conferences - Yahoo Finance
Have Insiders Sold Ardelyx Shares Recently? - simplywall.st
Ardelyx chief patient officer sells $41,419 in stock By Investing.com - Investing.com Australia
Ardelyx chief patient officer sells $41,419 in stock - Investing.com India
Ardelyx CCO Eric Foster sells $33,022 in stock - Investing.com India
Ardelyx CBO Mike Kelliher sells $29,921 in shares By Investing.com - Investing.com Canada
Ardelyx CCO Eric Foster sells $33,022 in stock By Investing.com - Investing.com Nigeria
Ardelyx CEO Michael Raab sells $225,914 in ARDX stock By Investing.com - Investing.com Canada
Ardelyx chief human resources officer sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx chief technical officer John Bishop sells $76,173 in stock - Investing.com India
Ardelyx SVP Joseph Reilly sells $15,358 of company stock By Investing.com - Investing.com Nigeria
Ardelyx chief technical officer John Bishop sells $76,173 in stock By Investing.com - Investing.com Nigeria
Ardelyx SVP Joseph Reilly sells $15,358 of company stock - Investing.com India
Ardelux CFO Susan Hohenleitner sells $6,009 in shares - Investing.com
Should Ardelyx’s Cut IBSRELA Guidance and CCO Exit Require Action From Ardelyx (ARDX) Investors? - simplywall.st
Ardelyx (NASDAQ: ARDX) holder plans tax sale of vesting shares - Stock Titan
Ardelyx (NASDAQ: ARDX) exec plans 10,500-share RSU tax sale - Stock Titan
Ardelyx (NASDAQ: ARDX) insider plans $179K stock sale - Stock Titan
Ardelyx (NASDAQ: ARDX) plans RSU tax-cover sale of 10,500 shares - Stock Titan
Ardelyx (ARDX) exec to sell $18.9K in shares for RSU taxes - Stock Titan
Ardelyx (NASDAQ: ARDX) shareholder John Bishop plans 25,500-share sale - stocktitan.net
Ardelyx (NASDAQ: ARDX) officer plans stock sales and tax-cover trades - Stock Titan
Ardelyx (ARDX) officer to sell 11,900 shares for RSU taxes - Stock Titan
334,115 Shares in Ardelyx, Inc. $ARDX Acquired by Clay Northam Wealth Management LLC - MarketBeat
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx (ARDX) Securities Investigation NoticeLevi & Korsinsky - Morningstar
Ardelyx (NASDAQ:ARDX) Sets New 52-Week LowHere's Why - MarketBeat
Ardelyx (ARDX) Earnings Update: EPS Falls Short of Its Estimate under the Current Snapshot; Investor Response: Shares Fall 2.61% at the CloseRevenue Inflection Point - vinanet.vn
Ardelyx (ARDX) Following Strong Results And Guidance Still Looks Undervalued - simplywall.st
ARDX Reiterates by Wedbush -- Price Target Maintained at $9.00 - GuruFocus
Exploring 3 High Growth Tech Stocks In The US Market - Sahm
Ardelyx Chief Commercial Officer Announces Upcoming Resignation - The Globe and Mail
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript - AOL.com
Ardelyx, Inc. (ARDX) Latest Stock News & Headlines - Yahoo Finance
Wedbush Reiterates Outperform Rating for Ardelyx (NASDAQ:ARDX) - MarketBeat
Ardelyx Leads The Charge With These 3 Compelling Penny Stocks - Sahm
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating - Moomoo
Ardelyx Announces Resignation of Chief Commercial Officer Eric Foster Effective August 28, 2026 - Kalkine Media
Ardelyx, Inc. Announces Resignation of Eric Foster from Chief Commercial Officer, Effective August 28, 2026 - marketscreener.com
ARDX Maintained by Piper Sandler -- Price Target Lowered to $15.00 - GuruFocus
Piper Sandler Lowers Ardelyx (NASDAQ:ARDX) Price Target to $15.00 - MarketBeat
ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX) - Business Wire
AIGH Capital Management LLC Buys Shares of 3,200,000 Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):